Nancy Simonian

Insider profile

Currently holds positions in Seagen Inc and Syros Pharmaceuticals Inc

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 18% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Seagen Inc March 19, 2012 -
President, Chief Executive Officer, Director Syros Pharmaceuticals Inc March 12, 2018 -
President, Chief Executive Officer, Director Syros Pharmaceuticals Inc March 12, 2018 - June 11, 2019
President, Chief Executive Officer, Chief Financial Officer, Director Syros Pharmaceuticals Inc Sept. 28, 2017 - March 12, 2018
President, Chief Executive Officer, Director Syros Pharmaceuticals Inc None -
Nancy Simonian's trades of Syros Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
57.06
Quantity 47,056
Value US$1,964,146
Transaction date
Proposed sale
Price
0.20
Quantity 134,713
Value US$26,943
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-04 2024-12-02
S Sale
26,768 +22.7%
269.07
US$3,239,397 		26,768 +22.7% 269.07 US$3,239,397
2024-12-02 2024-12-02
PrS Proposed sale
47,056
57.06
US$1,964,146 		47,056 57.06 US$1,964,146
2024-11-27 2024-11-25
S Sale
18,706 -37.3%
338.24
US$2,193,205 		18,706 -37.3% 338.24 US$2,193,205
2024-11-25 2024-11-25
PrS Proposed sale
134,713
0.20
US$26,943 		134,713 0.20 US$26,943